MicroPort NeuroTech (HKSE:02172) Debt-to-Equity : 0.04 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech Debt-to-Equity?

MicroPort NeuroTech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$26.0 Mil. MicroPort NeuroTech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$41.1 Mil. MicroPort NeuroTech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,788.9 Mil. MicroPort NeuroTech's debt to equity for the quarter that ended in Dec. 2023 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MicroPort NeuroTech's Debt-to-Equity or its related term are showing as below:

HKSE:02172' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.63 Med: 0.06 Max: 0.89
Current: 0.04

During the past 5 years, the highest Debt-to-Equity Ratio of MicroPort NeuroTech was 0.89. The lowest was -0.63. And the median was 0.06.

HKSE:02172's Debt-to-Equity is ranked better than
83.43% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs HKSE:02172: 0.04

MicroPort NeuroTech Debt-to-Equity Historical Data

The historical data trend for MicroPort NeuroTech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroTech Debt-to-Equity Chart

MicroPort NeuroTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.30

0.89

-0.63

0.06

0.04

MicroPort NeuroTech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			-0.63	-0.32	0.06	0.05	0.04

Competitive Comparison of MicroPort NeuroTech's Debt-to-Equity

For the Medical Devices subindustry, MicroPort NeuroTech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort NeuroTech's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's Debt-to-Equity falls into.

MicroPort NeuroTech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MicroPort NeuroTech's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26.017	+	41.098)	/	1788.881
	=	0.04

MicroPort NeuroTech's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26.017	+	41.098)	/	1788.881
	=	0.04

MicroPort NeuroTech (HKSE:02172) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

MicroPort NeuroTech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort NeuroTech (HKSE:02172) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN

Website

https://www.medneurotech.com

MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.

Executives

Hu Yibin
Biolink Biomedical Ltd.	2201 Interest of corporation controlled by you
Blossom Vision Limited	2201 Interest of corporation controlled by you
Lion Fish Limited	2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited	2301 Trustee
Thriving Hope Limited	2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership	2201 Interest of corporation controlled by you
Biolink Limited	2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines